Global Human Growth Hormone (hGH) Market Insights, Forecast to 2028

Growth hormone(GH),also known as somatotropin(or as human growth hormone [hGH or HGH] in its human form),is a peptide hormone that stimulates growth, cell reproduction,and cell regeneration in humans and other animals.
Market Analysis and Insights: Global Human Growth Hormone (hGH) Market
Due to the COVID-19 pandemic, the global Human Growth Hormone (hGH) market size is estimated to be worth US$ 253.9 million in 2022 and is forecast to a readjusted size of US$ 324.2 million by 2028 with a CAGR of 4.2% during the review period. Fully considering the economic change by this health crisis, Powder accounting for % of the Human Growth Hormone (hGH) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Growth Hormone Deficiency segment is altered to an % CAGR throughout this forecast period.
The growing application of growth hormones in treating many diseases and conditions has created a plethora of opportunities for the global human growth hormone market. The global market for human growth hormone is also being driven by the increasing awareness about the effectiveness of growth hormones in rectifying short statures. Children suffering from congenital conditions have significantly benefited from growth hormones. Meanwhile, adults with issues pertaining to pituitary gland have also led to a growing demand for human growth hormone therapies. Today, rising incidences of HIV/AIDS, growing research and development of long acting drugs, increasing cases of cancer, improving expenditure on healthcare, and commonly found growth hormone deficiencies have all augmented the global human growth hormone market.
Global Human Growth Hormone (hGH) Scope and Segment
Human Growth Hormone (hGH) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Human Growth Hormone (hGH) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Powder
Solvent
Segment by Application
Growth Hormone Deficiency
Turner Syndrome
Idiopathic Short Stature
Prader-Willi Syndrome
Small for Gestational Age
Others
By Company
Merck＆Co.，Inc
Eli Lilly and Company
Genentech，Inc.
Novo Nordisk
Sandoz International GmbH
Ferring Holding SA
Ipsen
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E